David T. Ting

22.9k citations

123 papers · 8.4k indexed · 2 hit papers · h-index 37

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology top 0.5%
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research

Papers in

Cancer Research 41
- Cancer Genomics and Diagnostics 31
Oncology 72
- Cancer Cells and Metastasis 32
- Pancreatic and Hepatic Oncology Research 25
- Cancer Immunotherapy and Biomarkers 14
- Colorectal Cancer Treatments and Studies 9

Co-authors: Daniel A. Haber Shyamala Maheswaran Mehmet Toner Shannon L. Stott Ben S. Wittner Sridhar Ramaswamy Min Yu Aditya Bardia
Journals: Cancer Research (11 papers)Journal of Clinical Oncology (10 papers)Clinical Cancer Research (7 papers)Cell Reports (6 papers)Nature Communications (5 papers)
Partner nations: United States Netherlands United Kingdom

In The Last Decade

David T. Ting

122 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis 2014 · 1.8k citations

Peers

Countries citing papers authored by David T. Ting

Since Specialization

Citations

This map shows the geographic impact of David T. Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Ting more than expected).

Fields of papers citing papers by David T. Ting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Ting. The network helps show where David T. Ting may publish in the future.

Co-authors

The 25 scholars most cited alongside David T. Ting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David T. Ting Line = papers co-authored together David T. Ting links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma Cancer Discovery ·А.О. Иванов, Clélia Cristina Neves Pinto, Erinma P. Ukoha, Siyu Sun, Patrick Danaher, Koldo Mitxelena, Константин Николаевич Панферов, Michael J. Raabe, C.Y. Lawrence Lok, Arif Muhammad Rifa'i, Aruna Venkatesan, N Amin Sahid, Paul K.S. Shin, Martin S. Taylor, Linda T. Nieman, Benjamin D. Greenbaum, David T. Ting	2025	1
2	β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma American Journal of Clinical Pathology ·CHAS. W. Prine, 高文轩, Steffen Rickelt, David T. Ting, Cristina R. Ferrone, Deepa T. Patil, Ömer Yılmaz, David L. Berger, Vikram Deshpande, 恵一上村	2024	1
3	Spatial transcriptomics reveals distinct tissue niches linked with steroid responsiveness in acute gastrointestinal GVHD Blood ·Clélia Cristina Neves Pinto, Michael J. Raabe, Yoshinori Shirai, C.Y. Lawrence Lok, Chenyue Lu, Vikram Deshpande, Linda T. Nieman, Martin J. Aryee, Yi‐Bin Chen, David T. Ting, Zachariah DeFilipp	2023	0
4	Quantitative p53 immunostaining aids in the detection of prevalent dysplasia Journal of Clinical Pathology ·Azfar Neyaz, Steffen Rickelt, Ömer Yılmaz, Simone Francisco Scandiuzzi, Chenyue Lu, Osman Yılmaz, Elizabeth Y. Wu, Won‐Tak Choi, Manish Gala, David T. Ting, Robert D. Odze, Deepa T. Patil, Vikram Deshpande	2023	1
5	The landscape of human SVA retrotransposons Nucleic Acids Research ·Chong Chu, Eric W. Lin, O.-C. Günther, Hu Jin, Koldo Mitxelena, Alexander Veit, Isidro Cortés‐Ciriano, Kathleen H. Burns, David T. Ting, Peter J. Park	2023	12
6	Immune microenvironment and lymph node yield in colorectal cancer British Journal of Cancer ·CHAS. W. Prine, 高文轩, Azfar Neyaz, 复旦开圆, Steffen Rickelt, Cristina R. Ferrone, David T. Ting, Deepa T. Patil, Ömer Yılmaz, David L. Berger, Vikram Deshpande, 恵一上村	2023	14
7	Clinical, pathological, genetics and intratumoural immune milieu of micropapillary carcinoma of the colon Journal of Clinical Pathology ·Vikram Deshpande, CHAS. W. Prine, I Goldberg, 高文轩, Azfar Neyaz, 复旦开圆, Steffen Rickelt, Антонина Хейфиц, Cristina R. Ferrone, David T. Ting, Deepa T. Patil, Ömer Yılmaz, David L. Berger, (unknown), (unknown)	2023	1
8	Proceedings of the inaugural Dark Genome Symposium: November 2022 Mobile DNA ·Jef D. Boeke, Kathleen H. Burns, Katherine B. Chiappinelli, Marie Classon, John M. Coffin, Pierre Ciotola, Joseph Dukes, Benjamin D. Greenbaum, George Kassiotis, Sarah K. Knutson, Arnold J. Levine, Avindra Nath, Sophie Papa, Daniel Ríos, John M. Sedivy, David T. Ting	2023	3
9	FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures Clinical Cancer Research ·Vishwajith Sridharan, Azfar Neyaz, R.L.M. Schils, Islam Baiev, Stephanie Reyes, Emily G. Barr Fritcher, Jochen K. Lennerz, William R. Sukov, Benjamin R. Kipp, David T. Ting, Vikram Deshpande, Lipika Goyal	2022	9
10	Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Clinical Cancer Research ·David Jérémie Birnbaum, Beata Świątek, Pascal Finetti, Charles Vanderburg, Anupriya S. Kulkarni, Azfar Neyaz, Thomas Hank, Eric C. Tai, Vikram Deshpande, François Bertucci, Daniel Birnbaum, Keith D. Lillemoe, Andrew L. Warshaw, Mari Mino–Kenudson, Carlos Fernández‐del Castillo, David T. Ting, Andrew S. Liss	2021	11
11	Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation Histopathology ·Azfar Neyaz, JJ Gomm, Angela Shih, Qing Zhao, Stuti G. Shroff, Martin S. Taylor, Steffen Rickelt, Jennifer Y. Wo, Carlos Fernández‐del Castillo, Motaz Qadan, Theodore S. Hong, Keith D. Lillemoe, David T. Ting, Cristina R. Ferrone, Vikram Deshpande	2020	10
12	Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern The American Journal of Surgical Pathology ·Anna M. Stagner, Dipti P. Sajed, G. Petur Nielsen, David H. Ebb, William C. Faquin, Ivan Chebib, Miguel N. Rivera, David T. Ting, Cory M. Resnick, Zachary S. Peacock, Leonard B. Kaban, Vikram Deshpande	2019	9
13	Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs) Clinical Cancer Research ·Lei Cai, Theodoros Michelakos, Vikram Deshpande, Kshitij S. Arora, Teppei Yamada, David T. Ting, Martin S. Taylor, Carlos Fernández‐del Castillo, Andrew L. Warshaw, Keith D. Lillemoe, Soldano Ferrone, Cristina R. Ferrone	2019	60
14	Enhanced Isolation and Release of Circulating Tumor Cells Using Nanoparticle Binding and Ligand Exchange in a Microfluidic Chip Journal of the American Chemical Society ·Myoung‐Hwan Park, Eduardo Reátegui, Wei Li, Shannon N. Tessier, Keith H.K. Wong, Anne Eeg Jensen, Vishal Thapar, David T. Ting, Mehmet Toner, Shannon L. Stott, Paula T. Hammond	2017	242
15	Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer Clinical Cancer Research ·Philip J. Saylor, Richard J. Lee, Kshitij S. Arora, Vikram Deshpande, Rong Hu, G. Reis Mitermayer, А. В. Гришко, Miguel N. Rivera, David T. Ting, Chin‐Lee Wu, David T. Miyamoto	2016	22
16	PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma Clinical Cancer Research ·Francesco Sabbatino, Vincenzo Villani, Jennifer H. Yearley, Vikram Deshpande, Lei Cai, Ioannis T. Konstantinidis, Christina Moon, Sjoerd Nota, Yangyang Wang, Ahmad Al-Sukaini, Andrew X. Zhu, Lipika Goyal, David T. Ting, Nabeel Bardeesy, Theodore S. Hong, Carlos Fernández‐del Castillo, Kenneth K. Tanabe, Keith D. Lillemoe, Soldano Ferrone, Cristina R. Ferrone	2015	162
17	MAPK7 Regulates EMT Features and Modulates the Generation of CTCs Molecular Cancer Research ·Sarah Javaid, Jianmin Zhang, Gromoslaw A. Smolen, Min Yu, Ben S. Wittner, Anurag Singh, Kshitij S. Arora, Marissa W. Madden, Rushil Desai, Matthew Zubrowski, Benjamin Schott, David T. Ting, Shannon L. Stott, Mehmet Toner, Shyamala Maheswaran, Toshi Shioda, Sridhar Ramaswamy, Daniel A. Haber	2015	35
18	Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis Cell ·Nicola Aceto, Aditya Bardia, David T. Miyamoto, Maria Donaldson Collier, Ben S. Wittner, Joel A. Spencer, Min Yu, К Д Казаченко, Amanda Engstrom, Huili Zhu, Brian W. Brannigan, Ravi Kapur, Shannon L. Stott, Toshi Shioda, Sridhar Ramaswamy, David T. Ting, Charles P. Lin, Mehmet Toner, Daniel A. Haber, Shyamala Maheswaran Hit paper breakdown →	2014	1786
19	Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition Science ·Min Yu, Aditya Bardia, Ben S. Wittner, Shannon L. Stott, Malgorzata E. Smas, David T. Ting, Steven J. Isakoff, Jordan C. Ciciliano, Editors Revue de Synthèse, Ajay M. Shah, Kyle Concannon, Maria Donaldson Collier, Lecia V. Sequist, Elena F. Brachtel, Dennis C. Sgroi, José Baselga, Sridhar Ramaswamy, Mehmet Toner, Daniel A. Haber, Shyamala Maheswaran Hit paper breakdown →	2013	1928
20	Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer Cancer Discovery ·David T. Miyamoto, Richard J. Lee, Shannon L. Stott, David T. Ting, Ben S. Wittner, Matthew Ulman, Malgorzata E. Smas, Jenna B. Lord, Brian W. Brannigan, Julie Trautwein, Neil H. Bander, Chin‐Lee Wu, Lecia V. Sequist, Matthew R. Smith, Sridhar Ramaswamy, Mehmet Toner, Shyamala Maheswaran, Daniel A. Haber	2012	217

About David T. Ting

David T. Ting is a scholar working on Cancer Research, Oncology, Immunology, Hepatology and Pulmonary and Respiratory Medicine, having authored 123 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (32 papers), Cancer Genomics and Diagnostics (31 papers), Pancreatic and Hepatic Oncology Research (25 papers), Cancer Immunotherapy and Biomarkers (14 papers), Colorectal Cancer Treatments and Studies (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (7 papers) and Genetic factors in colorectal cancer (6 papers). The work is most often cited by research in Cancer Research (2.9k citations), Oncology (4.4k citations), Molecular Biology (3.6k citations), Immunology (865 citations) and Cell Biology (560 citations). David T. Ting has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Daniel A. Haber, Shyamala Maheswaran, Mehmet Toner, Shannon L. Stott, Ben S. Wittner, Sridhar Ramaswamy, Min Yu, Aditya Bardia, Maria Donaldson Collier and Brian W. Brannigan. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Cell Reports and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact